What Are the Key Questions That Shape a Defective Drug Case?
In a pharmaceutical injury claim involving dangerous drugs, our Pasadena attorneys evaluate several factual and legal issues, including:
- Whether the medication carried adequate warning labels consistent with California Health & Safety Code § 111330, which prohibits misbranded drugs
- Whether safer alternative designs were available
- Whether similar injuries prompted recalls or safety alerts
- Whether regulatory submissions disclosed known risks
These factors help determine whether the product was reasonably safe when it left the manufacturer’s control. They also influence how the case is positioned in negotiation or litigation.
Regulatory Defenses and Manufacturer Accountability
Pharmaceutical defendants often rely on regulatory approval as a shield. This occurs because California Civil Code § 1714.45 provides limited protections when a drug has received FDA approval and includes warnings consistent with that approval.
However, that protection has limits. The statute does not apply if a manufacturer withheld material safety information or failed to update warnings after learning of new risks. Regulatory approval does not excuse concealment.
In many defective drug cases, the dispute centers on what the company knew and whether physicians and patients were fully informed. Our defective medication attorney in Pasadena evaluates post‑market safety reports, label revisions, and available scientific data to determine whether the statutory protection truly applies. This layer of analysis distinguishes pharmaceutical litigation from other product cases.
Evaluating the Impact of a Defective Medication
A dangerous medication can affect more than immediate health. It may alter your ability to work, require ongoing treatment, or permanently change daily function. State law permits recovery of economic and non‑economic damages when liability is established, including those recognized under California Civil Code § 1431.2.
Economic losses may include medical care, lost income, and reduced earning capacity. Non‑economic damages may address pain, emotional distress, and diminished quality of life. Proper evaluation of these damages often requires detailed documentation and, in many cases, expert support.
Drug manufacturers frequently attempt to narrow claims to isolated symptoms rather than long‑term consequences. Our Pasadena attorney structures each defective drug case around the full scope of harm, not a limited snapshot of early medical bills.
Get Started Today